Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The... see more

NDAQ:TLRY - Post Discussion

Tilray Brands, Inc. > Besides the $225 million wasted on Medmen, buying
View:
Post by Keeler on Mar 24, 2024 10:39am

Besides the $225 million wasted on Medmen, buying

a portion of their debt, Tilray also overspent buying Hexo for $250 million.

Hexo revenue had dropped for something like 8 quarters in a row - and sat at around $18 million a quarter at acquisition.

As indicated below, Tilray's cannabis  revenue gew from $59 million to $67 million after the acquisition of Hexo - meaning not only is there no organic growth - but the failed 'growth by acquisition' resulted in a lousy $9 million GROSS sales increase.

Simple Simon paid $250 million for a CANADIAN company that would report $36 million a year?
Brilliant.

Added to that insult is the fact that Hexo's costs were unbelievably out of control - they actually reported a NEGATIVE Gross Profit (profit after direct costs to produce the goods - but before operating expense). For every $1.00 sale - it was costing Hexo $1.40 to produce the product.

So while adding $9 million in sales - Hexo also contributed to Tilray's Gross Profit dropping to 30% from 50%, the industry average. Not enough for Tilray to pay it's cannabis  operating expense.

TLRY Tilray Brands - Better than Some



Post by Trendmaker1on Mar 24, 2024 10:07am
40 Views 
Post# 35949419

1 stock that I wouldn't touch

To be fair to Tilray, I would never buy any Canadian cannabis stock. The simple reason is that the market is has too many marijuana producers, driving up supply and pushing down prices. This is why you see Tilray getting into the alcohol industry and focusing on the international cannabis markets; the growth potential in the Canadian cannabis market just isn't appealing at all.

The end result is that generating significant revenue growth becomes difficult. Consider the company's most recent results as an example. For the period ended Nov. 30, Tilray reported $67.1 million in revenue from its cannabis business. But two years earlier, its cannabis revenue during the same period was $58.8 million. Over a two-year period, Tilray's cannabis revenue only grew by 14%, and that's with the help of acquisitions.

Comment by momocau on Mar 24, 2024 11:17am
NOW THAT YOU HAVE SAID ALL THESE NEGATIVE THINGS ABOUT TILRAY (( EXPLAINS TO INVESTORS WHY THE STOCKS ARE GOING UP LIKE THIS )) ITS PROVE THAT THE CEO'S DECISIONS WERE THE RIGHT ONE. CONTINUE YOUR GREAT WORK, MORE THAN YOU PUBLISH OUR ACTIONS ARE ON THE GREAT. WE CAN SEE THAT YOU ARE PAID TO DENIGRATE TILRAY 2024 IS GOING TO BE THE YEAR OF TILRAY. GOOD LUCK TO ALL OF YOU, TILRAY INVESTORS.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities